Archives
Cell Counting Kit-8 (CCK-8): Sensitive WST-8 Cell Viabili...
Cell Counting Kit-8 (CCK-8): Sensitive WST-8 Cell Viability Assay
Executive Summary: The Cell Counting Kit-8 (CCK-8) is a water-soluble tetrazolium salt-based assay enabling sensitive, quantitative measurement of cell viability and proliferation in vitro. CCK-8 uses WST-8, which is bioreduced by mitochondrial dehydrogenases in viable cells to produce a colored formazan dye measurable at 450 nm [product]. The assay correlates linearly with cell number and is less toxic to cells than MTT or XTT. CCK-8 is widely used in cancer, neurodegenerative disease, and cytotoxicity studies, and is referenced as a gold-standard in recent benchmarking literature (Brøndsted et al., 2025). The workflow is rapid, does not require solubilization steps, and is compatible with high-throughput microplate formats.
Biological Rationale
Cell viability and proliferation assays are essential in biomedical research for evaluating drug efficacy, cytotoxicity, and cell health. Quantifying viable cells informs experimental outcomes in oncology, neurobiology, and pharmacology. Traditional assays (e.g., MTT, XTT, MTS) use tetrazolium salts that are reduced by cellular dehydrogenases, yet these generate insoluble formazan products, complicating analysis. The Cell Counting Kit-8 (CCK-8) leverages a water-soluble tetrazolium salt, WST-8, enabling direct, non-destructive quantification of viable cells. The correlation between dehydrogenase activity and cell number forms the basis for sensitive and reproducible viability measurement [see contrast: CCK-8 is less toxic and more convenient than MTT as detailed in this article].
Mechanism of Action of Cell Counting Kit-8 (CCK-8)
The CCK-8 assay employs WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt), a highly water-soluble tetrazolium salt. In the presence of cellular NAD(P)H-dependent dehydrogenases, WST-8 is reduced to a water-soluble orange formazan dye. This reduction occurs exclusively in metabolically active (viable) cells, linking dye formation directly to cell viability. The reaction is facilitated by intracellular electron carriers, mainly within the mitochondrial respiratory chain [this article covers mitochondrial links in more depth]. The formazan product is soluble, allowing direct absorbance measurement at 450 nm without additional solubilization steps. The reaction proceeds at physiological temperature (37°C) and neutral pH, typically reaching completion within 1–4 hours depending on cell density.
Evidence & Benchmarks
- CCK-8 demonstrates a linear response with viable cell number from 500 to 100,000 cells per well (in 96-well format) under standard conditions (37°C, 5% CO2, 2 h incubation) (Brøndsted et al., 2025).
- WST-8-based detection is more sensitive and less cytotoxic than MTT, XTT, or WST-1, supporting serial measurements in the same well (ApexBio, K1018 datasheet).
- CCK-8 enables high-throughput analysis with coefficient of variation (CV) < 10% in replicates, facilitating screening applications (internal: advanced benchmarking in oxidative stress models).
- Compared to MTT, CCK-8 yields higher signal-to-background ratios and requires no organic solvents for dye solubilization (internal: mechanistic insight and workflow contrasts).
- WST-8 reduction is specific for metabolically active cells; dead or non-proliferating cells do not generate signal (internal: specificity and biological rationale).
Applications, Limits & Misconceptions
CCK-8 is widely used in cancer research, neurodegenerative disease studies, cytotoxicity profiling, and drug screening. The assay is compatible with a broad range of cell types, including adherent and suspension cultures, and can be multiplexed with other readouts (e.g., apoptosis, metabolic flux). CCK-8 is particularly advantageous for studies where cell recovery post-assay is needed, as it is non-destructive under standard conditions. The kit has been validated in oxidative stress, iron overload, and complex mRNA-LNP biodistribution models [this article highlights biodistribution and LNP studies].
Common Pitfalls or Misconceptions
- CCK-8 does not distinguish between increased metabolic activity and actual proliferation; increased signal may reflect altered metabolism rather than cell number.
- The assay is unreliable if cells are exposed to compounds that directly alter mitochondrial dehydrogenase activity independent of viability.
- Dead or apoptotic cells with residual metabolic activity can transiently reduce WST-8, leading to false-positive signals.
- Compounds with strong reducing potential (e.g., ascorbate, some antioxidants) may chemically reduce WST-8 non-enzymatically.
- Absorbance should be read promptly after incubation; prolonged incubation may result in non-linear responses or overestimation.
Workflow Integration & Parameters
The CCK-8 assay is compatible with standard microplate readers set to 450 nm. For optimal results, seed cells at densities yielding absorbance values within the linear range (typically 0.05–1.5 AU). Add 10 μL CCK-8 reagent per 100 μL culture medium per well (96-well format), incubate at 37°C, and measure absorbance after 1–4 hours. No washing or solubilization is required. The non-toxic nature of WST-8 allows downstream analyses (e.g., imaging, RNA extraction) post-assay. For batch reproducibility, control samples and blanks (media + reagent, no cells) are essential. The CCK-8 kit (K1018) is suited for automation and high-throughput workflows (see product protocol).
Conclusion & Outlook
Cell Counting Kit-8 (CCK-8) is a benchmark-sensitive, water-soluble tetrazolium salt-based assay for quantifying cell viability, proliferation, and cytotoxicity. Its high sensitivity, linearity, and ease of use make CCK-8 a standard tool for in vitro research across diverse biomedical fields. Users should be mindful of limitations related to metabolic modulation and potential chemical interference. With continued adoption in advanced models and high-throughput screening, CCK-8 remains foundational for translational and mechanistic cell biology studies (Brøndsted et al., 2025).